Gilead Sciences is an American pharmacological company which has been based in 1987. This is one of the most progressive pharmaceutical companies which works in the field of the biopharmaceutical technologies.
The product assortment of Gilead Sciences includes drugs for the treatment of HIV/AIDS, liver diseases, treatment and prophylaxis of the cancerous tumors, diseases of the cardiovascular system, inflammatory and respiratory diseases.
A scientific activity of Gilead Sciences is mainly focused on the research and development of the anti-viral drugs for the treatment of HIV, hepatitis B, hepatitis C, and influenza. Nowadays, Gilead Sciences has achieved a great success in exploration of this section of the pharmaceutical market.
As a result of the prolonged medical studies, the scientists of the company have managed to create a set of the medical products for the complete scheme of the treatment of HIV infection. Patients may orally take 1 pill a day to reduce the risk of the HIV infection and prevent the disease of the stage of the infection.
The assortment of the biopharmaceutical production of Gilead Sciences is not so big in comparison with the largest pharmaceutical corporations but every drug is very important for the progress in the field of the healthcare service.
Gilead Sciences develops drugs without any assistance as well as in collaboration with other pharmaceutical companies as a research center.
The portfolio of Gilead Sciences contains such drugs as Harvoni, Letairis, Lexiscan, Ranexa, Sovaldi, Vistide, Vitekta, Zydelig, Macugen, Flolan, Complera/Eviplera, Cayston, and Atripla.
Besides research and production activity, Gilead Sciences has a successful marketing policy and swallows up promising companies which diversify the production of the company and enable to enter new segments of the market.
Seven new pharmaceutical companies which have increased the efficiency of the development of the new drugs for the treatment of the oncologic diseases have joined Gilead Sciences corporation within the past 5 years.